Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1995 1
2005 1
2006 1
2007 1
2008 3
2009 4
2010 2
2011 4
2012 3
2013 2
2014 3
2015 1
2016 3
2017 2
2018 1
2019 4
2020 2
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, Van der Spek RA, Pliner HA, Shankaracharya, Smith BN, Marangi G, Topp SD, Abramzon Y, Gkazi AS, Eicher JD, Kenna A; ITALSGEN Consortium; Mora G, Calvo A, Mazzini L, Riva N, Mandrioli J, Caponnetto C, Battistini S, Volanti P, La Bella V, Conforti FL, Borghero G, Messina S, Simone IL, Trojsi F, Salvi F, Logullo FO, D'Alfonso S, Corrado L, Capasso M, Ferrucci L; Genomic Translation for ALS Care (GTAC) Consortium; Moreno CAM, Kamalakaran S, Goldstein DB; ALS Sequencing Consortium; Gitler AD, Harris T, Myers RM; NYGC ALS Consortium; Phatnani H, Musunuri RL, Evani US, Abhyankar A, Zody MC; Answer ALS Foundation; Kaye J, Finkbeiner S, Wyman SK, LeNail A, Lima L, Fraenkel E, Svendsen CN, Thompson LM, Van Eyk JE, Berry JD, Miller TM, Kolb SJ, Cudkowicz M, Baxi E; Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium; Benatar M, Taylor JP, Rampersaud E, Wu G, Wuu J; SLAGEN Consortium; Lauria G, Verde F, Fogh I, Tiloca C, Comi GP, Sorarù G, Cereda C; French ALS Consortium; Corcia P, Laaks… See abstract for full author list ➔ Nicolas A, et al. Neuron. 2018 Mar 21;97(6):1267-1288. doi: 10.1016/j.neuron.2018.02.027. Neuron. 2018. PMID: 29566793 Free PMC article.
A fluctuating nodule on the face.
Demirtas S, Plantin P, Lemasson G, Misery L, Abasq-Thomas C. Demirtas S, et al. Among authors: lemasson g. Pediatr Dermatol. 2020 May;37(3):557-558. doi: 10.1111/pde.14111. Pediatr Dermatol. 2020. PMID: 32598542 No abstract available.
Primary Gougerot-Sjögren syndrome: a dermatological approach.
Roguedas AM, Youinou P, Lemasson G, Pennec YL, Misery L. Roguedas AM, et al. Among authors: lemasson g. J Eur Acad Dermatol Venereol. 2006 Mar;20(3):243-7. doi: 10.1111/j.1468-3083.2006.01441.x. J Eur Acad Dermatol Venereol. 2006. PMID: 16503880 Review.
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.
Lombardo FL, Spila Alegiani S, Mayer F, Cipriani M, Lo Giudice M, Ludolph AC, McDermott CJ, Corcia P, Van Damme P, Van den Berg LH, Hardiman O, Nicolini G, Vanacore N, Dickie B, Albanese A, Puopolo M; TUDCA-ALS Study Group. Lombardo FL, et al. Trials. 2023 Dec 5;24(1):792. doi: 10.1186/s13063-023-07638-w. Trials. 2023. PMID: 38053196 Free PMC article. Clinical Trial.
Theme 4 In vivo experimental models.
Chudinova AV, Rossel M, Vergunst A, Le-Masson G, Camu W, Raoul C, Lumbroso S, Mouzat K. Chudinova AV, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):160-187. doi: 10.1080/21678421.2019.1646992. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31702459
PD-L1 expression in recurrent head and neck squamous cell carcinoma.
Delafoy A, Uguen A, Lemasson G, Conan-Charlet V, Pradier O, Lucia F, Schick U. Delafoy A, et al. Among authors: lemasson g. Eur Arch Otorhinolaryngol. 2022 Jan;279(1):343-351. doi: 10.1007/s00405-021-06777-7. Epub 2021 Apr 1. Eur Arch Otorhinolaryngol. 2022. PMID: 33796940
Progressive nodular histiocytosis improved by methotrexate.
Huet F, Brenaut E, Costa S, Lemasson G, Sonbol H, Misery L. Huet F, et al. Among authors: lemasson g. Eur J Dermatol. 2017 Dec 1;27(6):661-663. doi: 10.1684/ejd.2017.3115. Eur J Dermatol. 2017. PMID: 29165296 No abstract available.
[Pseudocyst of the scalp in a child].
Théréné C, Mairesse H, Lemasson G, Misery L, Brenaut E. Théréné C, et al. Among authors: lemasson g. Ann Dermatol Venereol. 2014 Jun-Jul;141(6-7):480-1. doi: 10.1016/j.annder.2014.03.005. Epub 2014 Apr 8. Ann Dermatol Venereol. 2014. PMID: 24951153 French. No abstract available.
Impact of expert pathology review in skin adnexal carcinoma diagnosis: Analysis of 2573 patients from the French CARADERM network.
Battistella M, Balme B, Jullie ML, Zimmermann U, Carlotti A, Crinquette M, Frouin E, Macagno N, Ortonne N, Lamant L, de la Fouchardiere A, Aubriot-Lorton MH, Durand L, Josselin N, Franck F, Chatelain D, Lemasson G, Algros MP, Durlach A, Machet MC, Courville P, Osio A, Seris A, Mortier L, Jouary T, Cribier B; CARADERM network. Battistella M, et al. Among authors: lemasson g. Eur J Cancer. 2022 Mar;163:211-221. doi: 10.1016/j.ejca.2021.11.027. Epub 2022 Jan 30. Eur J Cancer. 2022. PMID: 35090811
40 results